Nexera Robotics' adaptive NeuraGrasp will enable the Locus Array mobile manipulator to pick many more e-commerce SKUs.
Avaí Bio, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company developing transformative cell-based therapies for diabetes, age-related disorders, and anti-aging, today ...
When I first saw the announcement trailer for Luna Abyss, I was instantly intrigued by the aesthetics of the world that ...
Gaming has become a vital research area in the most advanced forms of decision algorithms, optimization, and procedural ...
Looking back at a New York Times magazine story to examine what responsible coverage of sex trafficking looks like—and what ...
Nexera’s patented NeuraGrasp™ technology vastly expands the range of SKUs Locus Array can pick autonomously, opening new SKU categories and mobile manipulation capabilities that have historically been ...
The 2026 EX60 is a clean-sheet, high-tech gamble that mostly pays off, but should you wait for Volvo's P12 version?
Republic Day 2026 Parade, Celebrations, Chief Guest, Padma Awards: The grand Republic Day parade is currently underway at the ...
Artificial intelligence and machine learning are shaping major design and research decisions for the planned Electron-Ion ...
Curious about the practical limits of infrared imaging, the independent engineering channel Project 326 developed a ...
3h
Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets
Market News Updates News Commentary - Cell-based therapies are quickly becoming one of the most talked-about areas in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results